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Celiac disease is a chronic systemic autoimmune disorder
induced by gluten proteins present in wheat, barley, and
rye. Celiac disease was originally described in 19th century
principally in children by Samuel Gee in England and
by Christian Herter in the United States. Until the mid-
20th century, celiac disease was known as Gee-Herter
disease. About two decade ago, celiac disease was considered
rare outside Europe and, therefore, was almost completely
ignored by health care professionals in rest of the world.
The initial diagnostic criteria laid down by the European
Society of Pediatric Gastroenterology and Nutrition in 1970
required three sets of intestinal histological evaluation, that
is, demonstration of villous atrophy on gluten containing
diet, normalization of villous atrophy on gluten-free diet
(GFD), and reappearance of villous atrophy on gluten re-
challenge. After 1990, relaxation of the diagnostic criteria
(reduction in number of biopsies required for the diagnosis
from three to one), increase in awareness, and availability of
the serological tests; celiac disease in the past 15–20 years has
become a global disease and has moved from obscurity into
the popular spotlight worldwide.
It was initially thought that gluten hypersensitivity in
celiac disease is limited to intestine only and all other features
are secondary to malabsorption,but it is now recognized that
many of the features of celiac disease may not be explained
on the basis of malabsorption alone. It is proposed that
the hypersensitivity to gluten is not limited to intestine
alone; many other organs are aﬀected independently of
intestinal involvement and celiac disease is now considered
as a systemic disease. Furthermore, celiac disease is not only
one disease caused by gluten; in fact there is a wide spectrum
of gluten related diseases. Gluten-related disorders have been
classified recently as allergic (wheat allergy), autoimmune
(celiac disease, dermatitis herpetiformis, and gluten ataxia),
and possibly immune-mediated (gluten sensitivity).
In this special issue on celiac disease, five articles have
highlighted various aspects of celiac disease. Approximately
30–50% of patients with celiac disease present to clinicians
with features other than gastrointestinal manifestations such
as with short stature, hypothyroidism, or type I diabetes to
endocrinologists; with refractory anemia to hematologists;
or with infertility or delayed menarche to gynecologists.
Emami M. H. and coauthors from Iran in this issue have
reported celiac disease in 5.9% (9/151) and 1.25% (3/173)
of patients presenting with typical and atypical features
of malabsorption. B. Admou et al. from Morocco have
discussed in a review article about the atypical presentation
of celiac disease and how to manage them.
Nine to 72% of patients with celiac disease have low
bone mineral density (BMD). On the other hand 4.5–12% of
patients having osteoporosis/osteopenia had a positive celiac
serology. The low BMD does not always normalize even
after years of GFD. This observation suggests that other than
malabsorption of calcium and phosphate, other mechanisms
are also involved. In an article on bone involvement in
celiac disease, T. Larussa et al. from Catanzaro, Italy, have
discussed epidemiology, mechanisms, and treatment of bone
involvement in patients with celiac disease.
Dermatitis herpetiformis is a cutaneous manifestation
of small intestinal immune mediated enteropathy precip-
itated by exposure to dietary gluten. It is characterised
by herpetiform clusters of pruritic urticated papules and
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vesicles on the skin, especially on the elbows, buttocks
and knees, and IgA deposits in the dermal papillae. While
dermatitis herpatiformis is a characteristic gluten-induced
skin disease; there are other dermatological manifestations
of celiac disease such as vitiligo, alopecia areata, psoriasis,
urticaria, atopic dermatitis, and cutaneous vasculitis. C.
Marzia et al. from Florence, Italy, have discussed in this issue
about the dermatological manifestations of celiac disease.
The management of celiac disease is very diﬀerent from
other gastrointestinal diseases and the core of the treatment
is dietary and nonmedicinal. The most eﬀective, most safe
and most aﬀordable treatment of celiac disease at present
is GFD. While prescribing GFD is easy, both institution
and maintenance of compliance to GFD are challenging.
The key to success is counseling by a nutrition specialist
and maintenance of compliance by the patient. All foods
and drugs that contain gluten and its derivatives must be
eliminated from the diet because even 50mg of gluten is
suﬃcient to cause a significant increase in the intestinal
mucosal damage.
Patients with celiac disease are more prone to physical,
psychological, and social strains than healthy children, which
influence the patients health-related quality of life (HRQOL)
not only because of disease but also because of restrictions
caused by GFD. It can be hard for children, adolescents, or
the adult patients with celiac disease to accept and comply
with the strict diet. Such an experience to patients with celiac
disease aﬀects their quality of life. I. M. Bystro¨m et al. from
Sweden, in this issue, have described the HRQOL in children
and adolescents with celiac disease from the perspectives
of children and parents. Children diagnosed before the age
of five had higher HRQOL than children diagnosed later.
Children who had the classical symptoms of the disease
at onset scored better on HRQOL scales than those who
had atypical symptoms or were asymptomatic. Moreover,
parents of children with celiac disease scored the HRQOL of
their children lower compared to that assessed by children
themselves.
Celiac disease is one of the ten diseases which are
often missed by doctors. Although absolute number of
patients with celiac disease at present is not very large, the
absolute number is however expected to increase markedly
all over the world during the next decade. There are many
issues which require immediate attention. The foremost of
them include increasing the awareness about the disease
amongst doctors and general population. A due emphasis
on celiac disease should be placed during undergraduate and
postgraduate curriculum. Furthermore, a constant reminder
about this disease should be provided to the physicians,
internists, gastroenterologists, hematologists, and endocri-
nologists through continuing medical education.
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